EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Compliance to Competitive Advantage in Pharma Supply
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
KNOWLEDGE BANK
-
Articles
Accelerated Approval Pathways: Speed Without the Stumbles
When a therapy for a devastating disease sits finished in a laboratory while patients wait the arithmetic of a traditional approval timeline becomes unbearable Europes accelerated approval pathways were built precisely for this moment to compress the distance between a promising molecule and a prescription pad
What Are the Implications of the Changing Regulatory Landscape in Europe?
In an age characterized by technological progress changing geopolitical scenarios and an increasing focus on sustainability businesses in Europe are grappling with an intricate network of regulatory shifts
Patient-Centered Approaches In Pharma: From R&D to the Future
The pharmaceutical industry is undergoing a paradigm shift towards patientcentered approaches recognizing the importance of considering patient perspectives throughout the drug development and healthcare delivery process
Advanced Robotics and Autonomous Operations in Pharma Production
Walk the production floor of almost any modern European pharmaceutical site and you will find robots already at work Sixaxis arms denest syringe tubs Gantries load and unload lyophilisers Autonomous mobile units ferry pallets between the warehouse and the dispensary Robotics arrived in pharmaceutical manufacturing more than two decades ago and in the purely mechanical sense the argument was won lo...
The Rise of Continuous Clinical Trials: Redefining Drug Development
The conventional clinical trial is a disposable asset A sponsor writes a protocol for a single compound activates a network of sites recruits a control group reads out and then dismantles everything it has built When the next candidate arrives often in the same disease often at the same hospitals
IoT Integration in Pharmaceutical Marketing: Revolutionizing Strategies for Success
The integration of Internet of Things technology in pharmaceutical marketing is transforming the way companies strategize for success IoT enables pharmaceutical companies to collect and analyze vast amounts of realtime data
-
Techno Trends
USF Researchers Identify New P. vivax Vaccine Target
Researchers at USF Health have identified a previously unknown vulnerability in Plasmodium vivax a major malaria parasite found across parts of Asia and Central and South America
-
Projects
Evonik Launches US$94 Million (EUR 80 million) Biotechnology Expansion in Slovakia
Evonik has commenced construction of a new biotechnology expansion at its Fermas facility in Slovensk upa Slovakia The development is part of an approximately US million investment EUR million
-
Research Insights
One-month physicochemical stability study of idarubicin prepared in polyolefin-type bags for the treatment of hematological diseases
Idarubicine is a mainstay of the treatment strategy for hematological cancer The literature lacks stability data that comply with current preparation practices and recommendations for conducting stability studies
-
whitepaper
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys
TOP ARTICLES
-
1
What Are the Implications of the Changing Regulatory Landscape in Europe?
Kate Williamson
The changing regulatory landscape in Europe, spanning data protection, digital services, climate action, finance, healthcare, Brexit impact, consumer protection, AI ethics, taxation, and telecommunica...
-
2
Patient-Centered Approaches In Pharma: From R&D to the Future
Kate Williamson
The pharmaceutical sector is experiencing a noteworthy transition towards patient-centered methodologies, integrating patient insights into research, embracing personalized medicine, incorporating dig...
-
3
Advanced Robotics and Autonomous Operations in Pharma Production
Lakshmi
European pharmaceutical plants are not short of robots. What they lack is autonomy — machines trusted to decide. This feature examines the shift from supervised automation to conditional autonom...
-
4
The Rise of Continuous Clinical Trials: Redefining Drug Development
Lakshmi
Clinical development is shifting from discrete, asset-anchored studies towards continuous platforms in which therapies enter and leave a standing trial under a single master protocol. Shared controls...
-
5
IoT Integration in Pharmaceutical Marketing: Revolutionizing Strategies for Success
Kate Williamson
"IoT Integration in Pharmaceutical Marketing: Revolutionizing Strategies for Success" explores the impact of IoT technology on pharmaceutical marketing strategies. It discusses benefits like...
press releases Read more...
VTv Therapeutics Announces Completion of Enrollment in Phase 3 CATT1 Study of Cadisegliatin in Type 1 Diabetes (T1D)
VTv Therapeutics Inc Nasdaq VTVT a latestage biopharmaceutical company advancing cadisegliatin a novel oral investigational therapy for type diabetes TD today announced that the Company has completed
Crescent Biopharma Announces FDA Clearance of IND Application for CR-002, a PD-L1-targeted Topoisomerase Inhibitor ADC, for the Treatment of Solid Tumors
Crescent Biopharma Inc Crescent or the Company Nasdaq CBIO a clinicalstage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients
Envirotainer expands Americas network with new and enhanced pharma cold chain stations
Envirotainer the global leader in secure cold chain solutions for temperaturesensitive pharmaceuticals is expanding its network across the Americas This expansion includes a new station in Los Angeles
Walden Biosciences to Present Phase 1+ and Phase 2 Data for WAL0921 at American Society of Nephrology Kidney Week
Walden Biosciences Inc Walden or the Company a private clinicalstage biotechnology company dedicated to developing diseasemodifying medicines to treat rare chronic kidney diseases
Events Read more...
05 - 06
Oct 2026ISPSAI France 2026
Paris, France
05 - 08
Oct 202616th World CB & CDx Summit 2026
Boston, MA, USA
12 - 13
Oct 2026Pharmaceutics 2026
Village Hotel Changi, Singapor...
12 - 13
Oct 20262nd International Conference on Drug Discovery
Village Hotel Changi, Singapor...
21 - 23
Oct 2026Drug Formulation & Drug Delivery 2026
Paris, France
21 - 22
Oct 2026Advance Clinical Trials and Research 2026
Paris, France
22 - 23
Oct 2026PDA Aseptic Symposium 2026
Congress Square Nakanoshima, O...
26 - 28
Oct 2026ACHEMA Middle East 2026
RICEC, Riyadh, KSA, Saudi Arab...
LATEST NEWS Read more...
Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialise EXPAREL® in the European Union and UK
Pacira BioSciences has entered into a strategic agreement with Molteni Farmaceutici to expand access to EXPAREL bupivacaine liposome injectable suspension for postsurgical pain management across selected European markets
ORIC Pharmaceuticals and Cancer Research UK Partner to Advance CIP2A-Targeted Cancer Therapy
ORIC Pharmaceuticals has entered into an agreement with Cancer Research UK to advance ORIC a potential firstinclass therapy targeting Cancerous Inhibitor of PPA CIPA into clinical development
AstraZeneca Opens New Global R&D Centre in Kendall Square, Cambridge, Massachusetts
AstraZeneca has opened a new global strategic research and development RD centre in Kendall Square Cambridge Massachusetts expanding its presence in the region and strengthening its global research capabilities
Quotient Sciences and Acesion Pharma collaborate on AI-enhanced formulation development
Quotient Sciences and Acesion Pharma have announced a collaboration to use AIenhanced formulation development to support Acesions earlystage pipeline of smallmolecule treatments for atrial fibrillation
Fresenius completes acquisition of mAbxience
Fresenius SE Co KGaA has completed the acquisition of the remaining stake in mAbxience from Insud Pharma giving Fresenius full ownership of the biopharmaceutical company
R1 Therapeutics expands Series A financing to $80.5 million
R Therapeutics has expanded its Series A financing to million with new investment from Samsara BioCapital The clinicalstage biopharmaceutical company will use the funding to advance AP




